Commenting on the decision today by the National Institute for Health and Clinical Excellence not to recommend everolimus (also known as Afinitor and made by Novartis Pharmaceuticals) for the treatment of postmenopausal women with HER2 negative hormone-receptor-positive secondary breast cancer* Grete Brauten-Smith Clinical Nurse Specialist at support charity Breast Cancer Care said:

“The draft guidance announced today by the National Institute for Health and Clinical Excellence (NICE) which does not recommend the use of Afinitor (everolimus) through the NHS in England and Wales will be disappointing news for people living with secondary breast cancer and their families.

“Through our services at Breast Cancer Care we support many people living with secondary breast cancer and know just how important it is for them to have access to treatments that could potentially extend their life expectancy.

“Whilst we recognise that drug decisions are complex treatment options for people living with secondary breast cancer are limited and Afinitor may help to prolong the life of people with incurable breast cancer.

“We therefore look forward to the results of the consultation period and await the final guidance issued from NICE so it may become widely available for eligible secondary breast cancer patients.

“Breast Cancer Care’s free and confidential helpline is available to anyone with questions about secondary breast cancer – 0808 800 6000 or for more information visit breastcancernow.org/secondaries

ENDS

Notes to editors:

For further media information please contact
Sophie Softley Pierce
0207 960 3505
sophie.pierce@breastcancercare.org.uk

About Breast Cancer Care
When breast cancer and its treatment overshadow everything we see the woman underneath. Breast Cancer Care is the only UK-wide charity dedicated to providing emotional and practical support for anyone affected. Our free helpline information-packed website and online forums offer a friendly ear and expert information to those dealing with this life-threatening disease. Across the UK we offer a range of confidential face-to-face services for people living with and beyond breast cancer. We campaign for better support and care and promote the importance of early detection involving people with breast cancer in all that we do. Visit breastcancernow.org or call our free helpline on 0808 800 6000.

*About secondary breast cancer
There are around 36000 people currently living with secondary breast cancer in the UK. Secondary breast cancer occurs when breast cancer cells spread from the first primary cancer in the breast to another distant part of the body via the bloodstream or lymphatic system. This type of spread is also known as metastases advanced breast cancer or stage 4 cancer. A diagnosis of secondary breast cancer means that the cancer cannot be cured although it can be treated and controlled sometimes for years.